End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.13 CNY | -0.95% | +0.97% | -6.57% |
04-25 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-6.57% | 1.1B | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- 600664 Stock
- News Harbin Pharmaceutical Group Co., Ltd.
- Roxatidine Hydrochloride for Injection of Harbin Pharma's Subsidiary Passes Drug Regulator's Evaluation